Literature DB >> 12150751

TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections.

Barbara J Stegmann1, J Christopher Carey.   

Abstract

Perinatal infections account for 2% to 3% of all congenital anomalies. TORCH, which includes Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections, are some of the most common infections associated with congenital anomalies. Most of the TORCH infections cause mild maternal morbidity, but have serious fetal consequences, and treatment of maternal infection frequently has no impact on fetal outcome. Therefore, recognition of maternal disease and fetal monitoring once disease is recognized are important for all clinicians. Knowledge of these diseases will help the clinician appropriately counsel mothers on preventive measures to avoid these infections, and will aid in counseling parents on the potential for adverse fetal outcomes when these infections are present.

Entities:  

Mesh:

Year:  2002        PMID: 12150751

Source DB:  PubMed          Journal:  Curr Womens Health Rep        ISSN: 1534-5874


  31 in total

1.  A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections.

Authors:  A Ardizzoni; B Capuccini; M C Baschieri; C F Orsi; F Rumpianesi; S Peppoloni; C Cermelli; M Meacci; A Crisanti; P Steensgaard; E Blasi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-05       Impact factor: 3.267

2.  Performance characteristics of current-generation Immulite 2000 TORCH Assays.

Authors:  A R Centonze; E Tonolli; R Fontana
Journal:  Clin Vaccine Immunol       Date:  2012-11-21

3.  Seroprevalence of TORCH infections in antenatal and HIV positive patient populations.

Authors:  Lavan Singh; Siddhartha Mishra; S Prasanna; M P Cariappa
Journal:  Med J Armed Forces India       Date:  2015-02-16

4.  GPER1 is required to protect fetal health from maternal inflammation.

Authors:  Alfred T Harding; Marisa A Goff; Heather M Froggatt; Jean K Lim; Nicholas S Heaton
Journal:  Science       Date:  2021-01-15       Impact factor: 47.728

5.  Zika virus E protein alters the properties of human fetal neural stem cells by modulating microRNA circuitry.

Authors:  Reshma Bhagat; Bharat Prajapati; Sonia Narwal; Nitin Agnihotri; Yogita K Adlakha; Jonaki Sen; Shyamala Mani; Pankaj Seth
Journal:  Cell Death Differ       Date:  2018-07-26       Impact factor: 15.828

6.  The plasma virome of febrile adult Kenyans shows frequent parvovirus B19 infections and a novel arbovirus (Kadipiro virus).

Authors:  Carolyne N Ngoi; Juliana Siqueira; Linlin Li; Xutao Deng; Peter Mugo; Susan M Graham; Matt A Price; Eduard J Sanders; Eric Delwart
Journal:  J Gen Virol       Date:  2016-10-24       Impact factor: 3.891

7.  Seroprevalence and Influence of Torch Infections in High Risk Pregnant Women: A Large Study from South India.

Authors:  K Rebekah Prasoona; B Srinadh; T Sunitha; M Sujatha; M L N Deepika; B Vijaya Lakshmi; Aruna Ramaiah; A Jyothy
Journal:  J Obstet Gynaecol India       Date:  2014-10-29

8.  Disorders of placental villous maturation in fetal death.

Authors:  Sunil Jaiman; Roberto Romero; Percy Pacora; Eunjung Jung; Gaurav Bhatti; Lami Yeo; Yeon Mee Kim; Bomi Kim; Chong Jai Kim; Jung-Sun Kim; Faisal Qureshi; Suzanne M Jacques; Offer Erez; Nardhy Gomez-Lopez; Chaur-Dong Hsu
Journal:  J Perinat Med       Date:  2020-04-01       Impact factor: 1.901

Review 9.  Effectiveness of interventions to screen and manage infections during pregnancy on reducing stillbirths: a review.

Authors:  Sidra Ishaque; Mohammad Yawar Yakoob; Aamer Imdad; Robert L Goldenberg; Thomas P Eisele; Zulfiqar A Bhutta
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

10.  Factors Associated With Toxoplasma gondii IgG and IgM Antibodies, and Placental Histopathological Changes Among Women With Spontaneous Abortion in Mwanza City, Tanzania.

Authors:  Illuminata Machumi; Mariam M Mirambo; Deodatus Ruganuza; Peter Rambau; Anthony N Massinde; Albert Kihunrwa; Stephen E Mshana; Domenica Morona
Journal:  East Afr Health Res J       Date:  2017-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.